rs3817672
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001128148.3(TFRC):c.424G>A(p.Gly142Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.513 in 1,611,674 control chromosomes in the GnomAD database, including 220,542 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_001128148.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TFRC | NM_001128148.3 | c.424G>A | p.Gly142Ser | missense_variant | Exon 4 of 19 | ENST00000360110.9 | NP_001121620.1 | |
TFRC | NM_003234.4 | c.424G>A | p.Gly142Ser | missense_variant | Exon 4 of 19 | NP_003225.2 | ||
TFRC | NM_001313965.2 | c.181G>A | p.Gly61Ser | missense_variant | Exon 3 of 18 | NP_001300894.1 | ||
TFRC | NM_001313966.2 | c.-412-1788G>A | intron_variant | Intron 2 of 16 | NP_001300895.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.425 AC: 64547AN: 151876Hom.: 15433 Cov.: 31
GnomAD3 exomes AF: 0.449 AC: 112205AN: 249668Hom.: 27642 AF XY: 0.458 AC XY: 61748AN XY: 134948
GnomAD4 exome AF: 0.522 AC: 761562AN: 1459680Hom.: 205106 Cov.: 43 AF XY: 0.520 AC XY: 377245AN XY: 726008
GnomAD4 genome AF: 0.425 AC: 64554AN: 151994Hom.: 15436 Cov.: 31 AF XY: 0.421 AC XY: 31284AN XY: 74298
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
TFRC-related combined immunodeficiency Benign:1
- -
not specified Benign:1
This variant is classified as Benign based on local population frequency. This variant was detected in 59% of patients studied by a panel of primary immunodeficiencies. Number of patients: 57. Only high quality variants are reported. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at